PMLiVE4d
AstraZeneca’s Tagrisso approved by FDA to treat EGFR-mutated lung cancer
Tagrisso (osimertinib) has been approved by the US Food and Drug Administration (FDA) to treat a new subset of lung cancer ...
PMLiVE6d
The partnership triangle
Wherever you sit in the partnership triangle, does it sound familiar? Many initiatives have tried to address this partnership ...
PMLiVE5d
Drug safety risk analysis – solving the puzzle of unstructured data
Traditional information gathering across the pharmaceutical industry, collected directly from healthcare professionals (HCPs) ...
PMLiVE5d
Eli Lilly/Almirall share positive long-term results for Ebglyss in atopic dermatitis
Eli Lilly and Almirall have announced positive long-term results for their targeted IL-13 inhibitor Ebglyss ...
PMLiVE7d
From lab to life: harnessing real-world evidence for informed clinical insights and improved patient outcomes
Picture this: a medicine targeting a particular disease is developed over 12-15 years from initial candidate selection, ...
PMLiVE5d
Sanofi’s Sarclisa granted FDA approval to treat newly diagnosed multiple myeloma
Sanofi’s Sarclisa (isatuximab) has been approved by the US Food and Drug Administration (FDA) as part of a first-line ...
PMLiVE6d
FDA approves Zevra’s Miplyffa as first drug for Niemann-Pick disease type C
The US Food and Drug Administration (FDA) has approved Zevra Therapeutics’ Miplyffa (arimoclomol) to treat Niemann-Pick ...
PMLiVE8d
Sanofi shares positive late-stage results for investigational BTK inhibitor in progressive MS
Sanofi has shared positive results from a late-stage study of its investigational BTK inhibitor, tolebrutinib, in patients ...
PMLiVE5d
Championing people-powered communications in rare diseases: AMICULUM’s feature in The Guardian Rare Diseases Campaign 2024
AMICULUM is delighted to have contributed to the MediaplanetUK Rare Diseases Campaign 2024, published in The Guardian on ...
PMLiVE5d
Advantages of Virtual Collaboration – Perks of Virtual Medical Education
From extended reach and enhanced interactivity to increased speed and flexibility, learn why virtual settings are becoming a ...
PMLiVE8d
EC approves Bavarian Nordic’s mpox vaccine Imvanex for use in adolescents
The European Commission (EC) has extended the marketing authorisation for Bavarian Nordic’s smallpox and mpox vaccine to ...
PMLiVE11d
Novo Nordisk and NanoVation to develop genetic medicines in partnership worth $600m
Novo Nordisk and NanoVation Therapeutics have entered into a multi-year partnership worth $600m to advance genetic medicines ...